Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teodora Wi

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Plos One|May 4, 2022
Assessment of country implementation of the WHO global health sector strategy on sexually transmitted infections (2016-2021)Melanie M Taylor, Teodora Wi, Antonio Gerbase, et al.
Genome Medicine|April 20, 2021
A community-driven resource for genomic epidemiology and antimicrobial resistance prediction of Neisseria gonorrhoeae at PathogenwatchLeonor Sánchez-Busó, Corin A Yeats, Benjamin Taylor, et al.
BMC Health Services Research|April 24, 2015
HIV service delivery models towards 'Zero AIDS-related Deaths': a collaborative case study of 6 Asia and Pacific countriesMasami Fujita, Krishna C Poudel, Kimberly Green, et al.
The Journal of Infectious Diseases|February 3, 2023
Whole-Genome Sequencing to Predict Antimicrobial Susceptibility Profiles in Neisseria gonorrhoeaeClaire C Bristow, Tatum D Mortimer, Sheldon Morris, et al.
The Journal of Antimicrobial Chemotherapy|March 18, 2025
Exceedingly high levels of tetracycline resistance in Neisseria gonorrhoeae in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-2024-doxycycline post-exposure prophylaxis will unlikely impact gonorrhoea burdensDaniel Schröder, Thitima Cherdtrakulkiat, Le Huu Doanh, et al.
IJID Regions|April 21, 2025
High susceptibility to the novel antimicrobial zoliflodacin among <i>Neisseria gonorrhoeae</i> isolates in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-2024Susanne Jacobsson, Thitima Cherdtrakulkiat, Daniel Golparian, et al.
The Journal of Antimicrobial Chemotherapy|December 16, 2025
High in vitro activity of the novel antimicrobial gepotidacin against Neisseria gonorrhoeae isolates in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-24Josefine Ahlstrand, Ismael Maatouk, Le Huu Doanh, et al.
The Lancet Regional Health. Western Pacific|September 9, 2025
Antimicrobial resistance in <i>Neisseria gonorrhoeae</i> in nine sentinel countries within the World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), 2023: a retrospective observational studyIsmael Maatouk, Phiona Vumbugwa, Thitima Cherdtrakulkiat, et al.
The Lancet. Global Health|July 23, 2024
WHO global research priorities for sexually transmitted infectionsSami L Gottlieb, Erica Spielman, Laith Abu-Raddad, et al.
The New England Journal of Medicine|October 15, 2015
Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors - Final ReportGibrilla F Deen, Nathalie Broutet, Wenbo Xu, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Plos One|May 4, 2022
Assessment of country implementation of the WHO global health sector strategy on sexually transmitted infections (2016-2021)Melanie M Taylor, Teodora Wi, Antonio Gerbase, et al.
Genome Medicine|April 20, 2021
A community-driven resource for genomic epidemiology and antimicrobial resistance prediction of Neisseria gonorrhoeae at PathogenwatchLeonor Sánchez-Busó, Corin A Yeats, Benjamin Taylor, et al.
BMC Health Services Research|April 24, 2015
HIV service delivery models towards 'Zero AIDS-related Deaths': a collaborative case study of 6 Asia and Pacific countriesMasami Fujita, Krishna C Poudel, Kimberly Green, et al.
The Journal of Infectious Diseases|February 3, 2023
Whole-Genome Sequencing to Predict Antimicrobial Susceptibility Profiles in Neisseria gonorrhoeaeClaire C Bristow, Tatum D Mortimer, Sheldon Morris, et al.
The Journal of Antimicrobial Chemotherapy|March 18, 2025
Exceedingly high levels of tetracycline resistance in Neisseria gonorrhoeae in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-2024-doxycycline post-exposure prophylaxis will unlikely impact gonorrhoea burdensDaniel Schröder, Thitima Cherdtrakulkiat, Le Huu Doanh, et al.
IJID Regions|April 21, 2025
High susceptibility to the novel antimicrobial zoliflodacin among <i>Neisseria gonorrhoeae</i> isolates in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-2024Susanne Jacobsson, Thitima Cherdtrakulkiat, Daniel Golparian, et al.
The Journal of Antimicrobial Chemotherapy|December 16, 2025
High in vitro activity of the novel antimicrobial gepotidacin against Neisseria gonorrhoeae isolates in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021-24Josefine Ahlstrand, Ismael Maatouk, Le Huu Doanh, et al.
The Lancet Regional Health. Western Pacific|September 9, 2025
Antimicrobial resistance in <i>Neisseria gonorrhoeae</i> in nine sentinel countries within the World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), 2023: a retrospective observational studyIsmael Maatouk, Phiona Vumbugwa, Thitima Cherdtrakulkiat, et al.
The Lancet. Global Health|July 23, 2024
WHO global research priorities for sexually transmitted infectionsSami L Gottlieb, Erica Spielman, Laith Abu-Raddad, et al.
The New England Journal of Medicine|October 15, 2015
Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors - Final ReportGibrilla F Deen, Nathalie Broutet, Wenbo Xu, et al.
Pageof 6